The Role of TROP2 in BCC and Cutaneous SCC: A Clinical and Immunohistochemical Study

Overview

Journal Clin Cosmet Investig Dermatol

Publisher Dove Medical Press

Specialty Dermatology

Date 2021 Jun 9

PMID 34103959

Authors

Azza Gaber Antar Farag

Hala Said El-Rebey

Mohamed Abd El-Moneim Shoeib

Shimaa Mohammed Ahmed El-Fiky

Mustafa Elsayed Elshaib

Amal Farid Mostafa

Affiliations

Soon will be listed here.

Abstract

Background: Nonmelanoma skin cancer (NMSC) mainly includes basal (BCC) and squamous (SCC) cell carcinoma. Trophoblast cell-surface antigen2 (TROP2), a cell-signal transduction, is one of the tumor-related calcium signal transducer gene family. TROP2 was highly expressed in many cancers, however, its role in BCC and SCC has not yet been studied.

Objective: To investigate TROP2 immunohistochemical expression in BCC and SCC (lesional and peri-lesional) skin compared to controls and correlates its expression with the clinicopathologic parameters of the studied cases.

Methods: This case-control study included 17 BCC and 15 SCC patients as well as 12 age and sex matched controls. History and clinical examination were completed. Histological examination of skin biopsies was done together with TROP2 immune-staining.

Results: In the studied BCC and SCC cases, there was a significant stepwise up-regulation of TROP2 H score from control to peri-lesional, ended by lesional epidermis in one hand (p=0.003 for BCC and p<0.001 for SCC) and tumor island in another hand (p=0.001 for BCC and p=0.003 for SCC). TROP2 expression in both BCC and SCC tumor tissues was not affected by any of the studied clinicopathological parameters of the investigated cases.

Conclusion: TROP2 could have an important role in BCC and SCC pathogenesis. TROP2 targeting may have appraising effect in clinical application in BCC and SCC management.

References

Higgins S, Nazemi A, Chow M, Wysong A . Review of Nonmelanoma Skin Cancer in African Americans, Hispanics, and Asians. Dermatol Surg. 2018; 44(7):903-910. DOI: 10.1097/DSS.0000000000001547. View

Lenart S, Lenart P, Smarda J, Remsik J, Soucek K, Benes P . Trop2: Jack of All Trades, Master of None. Cancers (Basel). 2020; 12(11). PMC: 7696911. DOI: 10.3390/cancers12113328. View

Lee K, Soyer H . Cutaneous keratinocyte cancers of the head and neck: Epidemiology, risk factors and clinical, dermoscopic and reflectance confocal microscopic features. Oral Oncol. 2019; 98:109-117. DOI: 10.1016/j.oraloncology.2019.09.019. View

Tang G, Tang Q, Jia L, Xia S, Li J, Chen Y . High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma. Pathol Res Pract. 2018; 214(10):1606-1612. DOI: 10.1016/j.prp.2018.07.017. View

Zeng P, Chen M, Zhou L, Tang M, Liu C, Lu P . Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis. Sci Rep. 2016; 6:33658. PMC: 5028884. DOI: 10.1038/srep33658. View

Ripani E, Sacchetti A, Corda D, Alberti S . Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer. 1998; 76(5):671-6. DOI: 10.1002/(sici)1097-0215(19980529)76:5<671::aid-ijc10>3.0.co;2-7. View

Cubas R, Zhang S, Li M, Chen C, Yao Q . Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer. 2010; 9:253. PMC: 2946292. DOI: 10.1186/1476-4598-9-253. View

Hong Y, Manoharan I, Suryawanshi A, Majumdar T, Angus-Hill M, Koni P . β-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells. Cancer Res. 2015; 75(4):656-665. PMC: 4333068. DOI: 10.1158/0008-5472.CAN-14-2377. View

Bardia A, Mayer I, Diamond J, Moroose R, Isakoff S, Starodub A . Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer. J Clin Oncol. 2017; 35(19):2141-2148. PMC: 5559902. DOI: 10.1200/JCO.2016.70.8297. View

10.

Stepan L, Trueblood E, Hale K, Babcook J, Borges L, Sutherland C . Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target. J Histochem Cytochem. 2011; 59(7):701-10. PMC: 3201164. DOI: 10.1369/0022155411410430. View

11.

Ibrahim A, Khaled H, Mikhail N, Baraka H, Kamel H . Cancer incidence in egypt: results of the national population-based cancer registry program. J Cancer Epidemiol. 2014; 2014:437971. PMC: 4189936. DOI: 10.1155/2014/437971. View

12.

Szeimies R, Torezan L, Niwa A, Valente N, Unger P, Kohl E . Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy. Br J Dermatol. 2012; 167(1):150-9. DOI: 10.1111/j.1365-2133.2012.10887.x. View

13.

Zhang B, Gao S, Li R, Li Y, Cao R, Cheng J . Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation. BMC Cancer. 2020; 20(1):815. PMC: 7450929. DOI: 10.1186/s12885-020-07257-7. View

14.

Hussein M, Al-Badaiwy Z, Guirguis M . Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions. J Cutan Pathol. 2004; 31(10):643-51. DOI: 10.1111/j.0303-6987.2004.00244.x. View

15.

Shvartsur A, Bonavida B . Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications. Genes Cancer. 2015; 6(3-4):84-105. PMC: 4426947. DOI: 10.18632/genesandcancer.40. View

16.

BALZAR M, Briaire-de Bruijn I, Prins F, Helfrich W, de Leij L, Riethmuller G . Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol. 2001; 21(7):2570-80. PMC: 86888. DOI: 10.1128/MCB.21.7.2570-2580.2001. View

17.

Kang J, Yun B, Song J, Shin M . Non-Melanocytic Skin Cancers of the Head and Neck: A Clinical Study in Jeju Province. Arch Plast Surg. 2017; 44(4):313-318. PMC: 5533053. DOI: 10.5999/aps.2017.44.4.313. View

18.

Liu T, Liu Y, Bao X, Tian J, Liu Y, Yang X . Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway. PLoS One. 2013; 8(9):e75864. PMC: 3785439. DOI: 10.1371/journal.pone.0075864. View

19.

Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S . Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer. 2004; 112(6):1029-35. DOI: 10.1002/ijc.20517. View

20.

Ulrich M, Maltusch A, Rowert-Huber J, Gonzalez S, Sterry W, Stockfleth E . Actinic keratoses: non-invasive diagnosis for field cancerisation. Br J Dermatol. 2007; 156 Suppl 3:13-7. DOI: 10.1111/j.1365-2133.2007.07865.x. View